TürkiyeDiagnosis and screening
In Istanbul, combined genetic tests confirmed 121 diagnoses among 135 people referred with suspected FSHD
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
At a center in Istanbul, 135 people were seen with suspected FSHD. First, the relevant region of the chromosome was measured. If the result was unclear, additional tests were done. In total, FSHD was confirmed in 121 people. Most of them had FSHD type 1. The disease was ruled out in six people, and no cause was found in five.
What does it mean for patients and families?
FSHD sometimes cannot be diagnosed with a single test. Using several methods together helps in difficult cases. This is a single-center study.
Source
Scientific paper: Integrated D4Z4 structural, epigenetic and exome-based evaluation of facioscapulohumeral muscular dystrophy in a tertiary referral cohort from Türkiye. Journal of Medical Genetics, 2026. DOI: 10.1136/jmg-2026-111660 · PubMed 42498520
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Facioscapulohumeral muscular dystrophy (FSHD)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.